Patents by Inventor Nilesh Jaiswal

Nilesh Jaiswal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210369619
    Abstract: The present invention relates to the transmucosal dosage forms like sublingual pharmaceutical compositions comprising antiviral molecules like favipiravir, remdesivir, baloxavir marboxil, molnupiravir, besifovir, raltegravir, GS-441524, ravidasvir, and other antiviral drugs. The present invention also relates to methods for preparing these transmucosal pharmaceutical compositions. Compositions prepared as per the present invention are able to increase bioavailability by avoiding first-pass metabolism. The compositions prepared as per the present invention exhibit desired pharmaceutical technical attributes such as pH, assay, related substance, disintegration, and dissolution. The compositions prepared as per the present invention are useful in the treatment of viral infections including coronavirus infection (COVID-19).
    Type: Application
    Filed: May 25, 2021
    Publication date: December 2, 2021
    Applicant: Jubilant Generics Limited
    Inventors: Indranil Nandi, Tusharmouli Mukherjee, Dinesh Kumar, Anil Jain, Pankaj Soni, Gaurav Navinbhai Mistry, Nilesh Jaiswal
  • Publication number: 20140080864
    Abstract: The present invention relates to a pharmaceutical composition of drotaverine hydrochloride in a solvent system suitable as a liquid fill composition. In another aspect, the invention also relates to a process for the preparation of a pharmaceutical composition and to the use of the composition for treating spasms and acute pains.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 20, 2014
    Applicant: CHINOIN PRIVATE CO LTD
    Inventors: Sudhakara Rao BADABHAGNI, Nilesh JAISWAL, Praveen KHULLAR, Kum PRASAD
  • Publication number: 20140073670
    Abstract: The present invention relates to a pharmaceutical formulation of fexofenadine hydrochloride in a solvent system suitable as a liquid fill composition. In another aspect, the invention also relates to a process for the preparation of the pharmaceutical formulation and the use of the composition for the treatment of allergic reactions in a patient.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 13, 2014
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Sudhakara Rao BADABHAGNI, Nilesh JAISWAL, Praveen KHULLAR, Kum PRASAD
  • Publication number: 20140073698
    Abstract: The present invention relates to a pharmaceutical formulation of ketoprofen sodium salts in a hydrophilic solvent system suitable as a liquid fill composition. In another aspect, the invention also relates to a process for the preparation of a pharmaceutical formulation and the use of the formulation for treating inflammatory pains.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 13, 2014
    Applicant: Aventis Pharma S.A.
    Inventors: Sudhakara Rao BADABHAGNI, Nilesh JAISWAL, Praveen KHULLAR, Kum PRASAD
  • Publication number: 20130146496
    Abstract: The present invention is directed to solid stable pharmaceutical fixed dose compositions comprising ramipril, amlodipine besilate and pharmaceutically acceptable excipients, and to their preparation.
    Type: Application
    Filed: August 23, 2012
    Publication date: June 13, 2013
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Praveen Khullar, Amol Kulkarni, Nilesh Jaiswal, Dilip PRAJAPATI